Zaidi M, Shankar V S, Adebanjo O A, Lai F A, Pazianas M, Sunavala G, Spielman A I, Rifkin B R
Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.
Am J Physiol. 1996 Sep;271(3 Pt 2):F637-44. doi: 10.1152/ajprenal.1996.271.3.F637.
Certain eukaryotic cells can sense changes in their extracellular Ca2+ concentration through molecular structures termed Ca(2+)-sensing receptors (CaRs). We have shown recently that in the bone-resorbing osteoclast, a unique cell surface-expressed ryanodine receptor (RyR), functions as the CaR. The present study demonstrates that the sensitivity of this receptor is modulated by physiological femtomolar concentrations of the bone-conserving hormone, calcitonin. Calcitonin was found to inhibit cytosolic Ca2+ responses to both Ca2+ and Ni2+. The latter inhibition was mimicked by amylin (10(-12) M), calcitonin gene-related peptide (10(-12) M), cholera toxin (5 micrograms/l) and dibutyryl adenosine 3',5'-cyclic monophosphate (cAMP) (2.5 x 10(-4) or 5 x 10(-4) M) and was reversed by the protein kinase A phosphorylation inhibitor, IP-20. Finally, using a quench flow module, we showed that cellular cAMP levels rise to a peak within 25 ms of calcitonin application; this is consistent with the peptide's rapid effect on CaR activation. We conclude, therefore, that cAMP plays a critical role in the control of CaR function by calcitonin.
某些真核细胞能够通过被称为钙敏感受体(CaRs)的分子结构来感知细胞外Ca2+浓度的变化。我们最近发现,在骨吸收破骨细胞中,一种独特的细胞表面表达的兰尼碱受体(RyR)发挥着钙敏感受体的作用。本研究表明,这种受体的敏感性受到保骨激素降钙素生理飞摩尔浓度的调节。发现降钙素可抑制细胞溶质Ca2+对Ca2+和Ni2+的反应。胰岛淀粉样多肽(10-12 M)、降钙素基因相关肽(10-12 M)、霍乱毒素(5微克/升)和二丁酰腺苷3',5'-环磷酸单酯(cAMP)(2.5×10-4或5×10-4 M)可模拟后者的抑制作用,并且该抑制作用可被蛋白激酶A磷酸化抑制剂IP-20逆转。最后,使用淬灭流动模块,我们发现细胞cAMP水平在应用降钙素后25毫秒内升至峰值;这与该肽对钙敏感受体激活的快速作用一致。因此,我们得出结论,cAMP在降钙素对钙敏感受体功能的控制中起关键作用。